2009
DOI: 10.1016/j.spinee.2009.08.429
|View full text |Cite
|
Sign up to set email alerts
|

P168. Osteolysis in Posterior and Transforaminal Lumbar Interbody Fusion with Bone Morphogenic Protein-2

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2011
2011
2011
2011

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Other data provided by government regulators and other medical publications documented that up to 50% of patients treated with InFuse experienced significant complications and side effects, including bone osteolysis and ectopic bone growth, inflammatory reactions including radiculitis, graft subsidence and migration, infertility in men, and concerns regarding carcinogenesis. 11 Contrary to this has been the experience of a single neurosurgeon spine specialist (the author), who, in a series of fusion cases extending from 1992 to 2010 and involving more than 700 patients, has utilized autologous bone marrow (rather than bioengineered substances) and locally harvested autologous bone for the purpose of enhancing bone fusion. Autologous bone marrow actually contains bone morphogenetic protein and is even better than bone morphogenetic protein because it also contains stem cells to further power the osteogenic process.…”
Section: The Biosorb Experimentsmentioning
confidence: 99%
“…Other data provided by government regulators and other medical publications documented that up to 50% of patients treated with InFuse experienced significant complications and side effects, including bone osteolysis and ectopic bone growth, inflammatory reactions including radiculitis, graft subsidence and migration, infertility in men, and concerns regarding carcinogenesis. 11 Contrary to this has been the experience of a single neurosurgeon spine specialist (the author), who, in a series of fusion cases extending from 1992 to 2010 and involving more than 700 patients, has utilized autologous bone marrow (rather than bioengineered substances) and locally harvested autologous bone for the purpose of enhancing bone fusion. Autologous bone marrow actually contains bone morphogenetic protein and is even better than bone morphogenetic protein because it also contains stem cells to further power the osteogenic process.…”
Section: The Biosorb Experimentsmentioning
confidence: 99%